Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3199055 | Journal of Allergy and Clinical Immunology | 2011 | 13 Pages |
Abstract
When compared with desloratadine and placebo, Ze 339 shows better efficacy in relieving nasal obstruction symptoms and inhibiting critical components of the chemokine network and as such represents a novel symptomatic and possible prophylactic treatment for allergic rhinitis.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Alina F. MD, Mohamed PhD, Martin MD, Simone MD, Kathrin MD, Jens MD, Thomas MD, Lorenzo MSc, Sabine PhD, Christian PhD, Catherine PhD, Carsten B. PhD, Adam M. MD,